Skip to content

Fact Sheet

About Illumina

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With rapid advances in technology taking place, it is mission-critical to offer solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service.

We strive to meet this challenge by placing a high value on collaborative interactions, rapid delivery of solutions, and meeting the needs of our customers.

Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.

Quick Facts
  • Website:
  • Ticker symbol:
  • Headquarters:
    San Diego, California, USA
  • Number of employees:
    5,500+ globally
  • 2016 revenue:
    $2.4 Billion USD

The Illumina mission

We take our mission seriously and engrain it in everything we do.

Our mission statement:
To improve human health by unlocking the power of the genome.

Leading-edge products and services

Illumina has developed a comprehensive line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. Our broad portfolio of leading-edge sequencing and array-based solutions address a range of genomic complexity and throughput, enabling researchers to select the best solution for their scientific challenge.


  • NovaSeq Sequencing Systems
  • HiSeq X Sequencing Systems
  • HiSeq Sequencing Systems
  • NextSeq Sequencing Systems
  • MiSeq Sequencing System
  • MiSeqDx Sequencing System
  • MiSeq FGx Forensic Genomics System
  • MiniSeq Sequencing System
  • iSeq 100 System
  • HiScan Array Scanner
  • iScan Array Scanner


  • AmpliSeq for Illumina
  • TruSeq, TruSight, and Nextera technologies
  • Sequencing by synthesis chemistry
  • Infinium genotyping and methylation assays

Commercial offices

  • San Diego, CA
  • San Francisco, CA
  • Madison, WI
  • Sao Paulo, Brazil
  • Cambridge, UK
  • Eindhoven, Netherlands
  • Beijing, China
  • Shanghai, China
  • Singapore
  • Osaka, Japan
  • Tokyo, Japan
  • Melbourne, Australia

Illumina Management Team

  • Francis deSouza
    President and Chief Executive Officer
  • Garret Hampton
    Executive Vice President, Clinical Genomics
  • Omead Ostadan
    Executive Vice President, Products & Operations
  • Aimee Hoyt
    Senior Vice President & Chief People Officer
  • Charles Dadswell
    Senior Vice President & General Counsel
  • Mostafa Ronaghi, PhD
    Senior Vice President & Chief Technology Officer
  • Sam Samad
    Senior Vice President & Chief Financial Officer
  • Mark Van Oene
    Senior Vice President & Chief Commercial Officer